Pradaxa’s Issues (Part II)
Updated: 2012-06-28 19:33:50
Several days ago, a compendium of the safety reports of the FDA was published by the Institute for Safe Medical Practices. These safety reports arrive at the FDA in several ways. They are reported to the FDA by drug companies, by physicians and by patients. The Institute for Safe Medical Practices is an independent nonprofit [...]

I am always surprised that patients will take all sorts of nutritional products, or what we call nutraceuticals, but are loath to take drugs that have been tested and vetted to do what they are supposed to do. This becomes most evident when the discussions of statins arises particularly in primary prevention. Patients are not [...]
At times there is a significant disconnect between facts, theory and use in medicine. Instead of facts and science, physicians and patients substitute urban legend and wishful thinking. Why some trends are so hard to change has often been a mystery to me. This is especially true when the habit that should be changed causes [...]
This concept of dark chocolate being a health benefit has been postulated before and actually has a scientific basis. Published in the Journal of Cardiovascular Pharmacology in November 2010 was an article describing the effects of eating dark chocolate on normal participants of a small study. These participants ate 75 grams of dark unsweetened chocolate [...]
An article was published last week that brought joy to my mother’s heart. I find articles of this nature somewhat disingenuous, but they do in some way serve a purpose. This article was published in the British Medical Journal (BMJ 2012;344:e3657) and is titled “The effectiveness and cost effectiveness of dark chocolate consumption as preventive [...]
It is the end of one age and the beginning of another. Two drugs that accounted for the number one and number two selling drugs in the world are now both generic. The two drugs together had roughly $25 billion in sales…a year. In the United States in 2010, Lipitor sold $5,272,576,000 and Plavix sold $4,675,483,000. [...]